NCT04842604 2023-12-18Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMMLPfizerPhase 3 Completed14 enrolled 11 charts
NCT01546038 2020-03-03A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromePfizerPhase 2 Completed255 enrolled 82 charts 1 FDA